Adiposity significantly modifies genetic risk for dyslipidemia

Journal of Lipid Research

Volumn 55, Issue 11, 2014, Pages 2416-2422

  Cole, Christopher B ^a   Nikpay, Majid ^a   Lau, Paulina ^a   Stewart, Alexandre F R ^a   Davies, Robert W ^a   Wells, George A ^a   Dent, Robert ^b   McPherson, Ruth ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Genetic risk score; Lipoproteins; Obesity; Single nucleotide polymorphism; Statistical interaction

Indexed keywords

APOLIPOPROTEIN A5; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID TRANSFER PROTEIN; TRIACYLGLYCEROL;

ADULT; APOA5 GENE; ARTICLE; BODY MASS; CETP GENE; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; GALNT2 GENE; GCKR GENE; GENE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE FUNCTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HERITABILITY; HUMAN; LEAN BODY WEIGHT; LIPG GENE; LIPID BLOOD LEVEL; LPL GENE; MALE; OBESITY; PLTP GENE; RISK ASSESSMENT; SCORING SYSTEM; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; BLOOD; GENETICS; METABOLISM; MIDDLE AGED;

ADIPOSITY; AGED; BODY MASS INDEX; CHOLESTEROL, HDL; DYSLIPIDEMIAS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TRIGLYCERIDES;

EID: 84912054998     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.P052522     Document Type: Article

References (21)

1. Teslovich, T. M., K. Musunuru, A. V. Smith, A. C. Edmondson, I. M. Stylianou, M. Koseki, J. P. Pirruccello, S. Ripatti, D. I. Chasman, C. J. Willer, et al. 2010. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 466: 707-713.
2. Willer, C. J., E. M. Schmidt, S. Sengupta, G. M. Peloso, S. Gustafsson, S. Kanoni, A. Ganna, J. Chen, M. L. Buchkovich, S. Mora, et al. 2013. Discovery and refinement of loci associated with lipid levels. Nat. Genet. 45: 1274-1283.
3. Johansen, C. T., J. Wang, M. B. Lanktree, A. D. McIntyre, M. R. Ban, R. A. Martins, B. A. Kennedy, R. G. Hassell, M. E. Visser, S. M. Schwartz, et al. 2011. An increased burden of common and rare lipid-associated risk alleles contributes to the phenotypic spectrum of hypertriglyceridemia. Arterioscler. Thromb. Vasc. Biol. 31: 1916-1926.
4. Namboodiri, K. K., E. B. Kaplan, I. Heuch, R. C. Elston, P. P. Green, D. C. Rao, P. Laskarzewski, C. J. Glueck, and B. M. Rifkind. 1985. The Collaborative Lipid Research Clinics Family Study: biological and cultural determinants of familial resemblance for plasma lipids and lipoproteins. Genet. Epidemiol. 2: 227-254.
5. Yu, Y., D. F. Wyszynski, D. M. Waterworth, S. D. Wilton, P. J. Barter, Y. A. Kesaniemi, R. W. Mahley, R. McPherson, G. Waeber, T. P. Bersot, et al. 2005. Multiple QTLs influencing triglyceride and HDL and total cholesterol levels identified in families with atherogenic dyslipidemia. J. Lipid Res. 46: 2202-2213.
6. Howard, B. V., G. Ruotolo, and D. C. Robbins. 2003. Obesity and dyslipidemia. Endocrinol. Metab. Clin. North Am. 32: 855-867.
7. Ahituv, N., N. Kavaslar, W. Schackwitz, A. Ustaszewska, J. Martin, S. Hebert, H. Doelle, B. Ersoy, G. Kryukov, S. Schmidt, et al. 2007. Medical sequencing at the extremes of human body mass. Am. J. Hum. Genet. 80: 779-791.
8. Davies, R. W., P. Lau, T. Naing, M. Nikpay, H. Doelle, M. E. Harper, R. Dent, and R. McPherson. 2013. A 680 kb duplication at the FTO locus in a kindred with obesity and a distinct body fat distribution. Eur. J. Hum. Genet. 21: 1417-1422.
9. Davies, R. W., G. A. Wells, A. F. Stewart, J. Erdmann, S. H. Shah, J. F. Ferguson, A. S. Hall, S. S. Anand, M. S. Burnett, S. E. Epstein, et al. 2012. A genome-wide association study for coronary artery disease identifies a novel susceptibility locus in the major histocompatibility complex. Circ. Cardiovasc. Genet. 5: 217-225.
10. Dandona, S., A. F. Stewart, L. Chen, K. Williams, D. So, E. O'Brien, C. Glover, M. Lemay, O. Assogba, L. Vo, et al. 2010. Gene dosage of the common variant 9p21 predicts severity of coronary artery disease. J. Am. Coll. Cardiol. 56: 479-486.
11. Schunkert, H., I. R. Konig, S. Kathiresan, M. P. Reilly, T. L. Assimes, H. Holm, M. Preuss, A. F. Stewart, M. Barbalic, C. Gieger, et al. 2011. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat. Genet. 43: 333-338.
12. Howie, B. N., P. Donnelly, and J. Marchini. 2009. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5: e1000529.
13. Dudbridge, F. 2013. Power and predictive accuracy of polygenic risk scores. PLoS Genet. 9: e1003348.
14. Purcell, S., B. Neale, K. Todd-Brown, L. Thomas, M. A. Ferreira, D. Bender, J. Maller, P. Sklar, P. I. de Bakker, M. J. Daly, et al. 2007. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81: 559-575.
15. Davies, R. W., S. Dandona, A. F. Stewart, L. Chen, S. G. Ellis, W. H. Tang, S. L. Hazen, R. Roberts, R. McPherson, and G. A. Wells. 2010. Improved prediction of cardiovascular disease based on a panel of SNPs identified through genome wide association studies. Circ. Cardiovasc. Genet. 3: 468-474.
16. Benjamini, Y., and Y. Hochberg. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B. 57: 289-300.
17. Li, S., J. H. Zhao, J. Luan, U. Ekelund, R. N. Luben, K. T. Khaw, N. J. Wareham, and R. J. Loos. 2010. Physical activity attenuates the genetic predisposition to obesity in 20,000 men and women from EPIC-Norfolk prospective population study. PLoS Med. 7: e1000332.
18. Beer, N. L., N. D. Tribble, L. J. McCulloch, C. Roos, P. R. Johnson, M. Orho-Melander, and A. L. Gloyn. 2009. The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver. Hum. Mol. Genet. 18: 4081-4088.
19. Grosskopf, I., N. Baroukh, S. J. Lee, Y. Kamari, D. Harats, E. M. Rubin, L. A. Pennacchio, and A. D. Cooper. 2005. Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants. Arterioscler. Thromb. Vasc. Biol. 25: 2573-2579.
20. Wu, Y., A. F. Marvelle, J. Li, D. C. Croteau-Chonka, A. B. Feranil, C. W. Kuzawa, Y. Li, L. S. Adair, and K. L. Mohlke. 2013. Genetic association with lipids in Filipinos: waist circumference modifies an APOA5 effect on triglyceride levels. J. Lipid Res. 54: 3198-3205.
21. Schjoldager, K. T., M. B. Vester-Christensen, E. P. Bennett, S. B. Levery, T. Schwientek, W. Yin, O. Blixt, and H. Clausen. 2010. O-glycosylation modulates proprotein convertase activation of angiopoietin-like protein 3: possible role of polypeptide GalNAc-transferase-2 in regulation of concentrations of plasma lipids. J. Biol. Chem. 285: 36293-36303.